DEFINITIVE PROXY STATEMENT

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

February 6, 2020

Period of Report

February 18, 2020

Accession Number

0001104659-20-011895

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →